Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS-0200 and NS-0300 for Weight Loss in Obesity
NCT03364335Phase 2Completed
- Sponsor
- NuSirt Biopharma
- Start
- Jan 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of l-leucine, sildenafil, metformin in obesity, sponsored by NuSirt Biopharma. Started Jan 2018; status: completed.
02
Drugs
l-leucinesildenafilmetformin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03364335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03364335.